Kura Oncology (KURA) Reports In-Line Q3 EPS

Kura Oncology (NASDAQ: KURA) reported Q3 EPS of ($0.63), in-line with the analyst estimate of ($0.63).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
• Quanterix Corp. (QTRX) PT Lowered to $3 at Canaccord